These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 33534277)
1. Take-Home Naloxone and the Need for a Publicly Funded Naloxone Supply. Kim HS; Aks SE J Addict Med; 2022 Jan-Feb 01; 16(1):1-3. PubMed ID: 33534277 [TBL] [Abstract][Full Text] [Related]
2. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621 [TBL] [Abstract][Full Text] [Related]
4. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019. Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856 [TBL] [Abstract][Full Text] [Related]
5. Take-Home Naloxone and the Prevention of Deaths from Heroin Overdose: Pursuing Strong Science, Fuller Understanding, Greater Impact. Strang J Eur Addict Res; 2022; 28(3):161-175. PubMed ID: 34963112 [TBL] [Abstract][Full Text] [Related]
6. Moving Naloxone Over the Counter Is Necessary but Not Sufficient. Messinger JC; Beletsky L; Kesselheim AS; Barenie RE Ann Intern Med; 2023 Aug; 176(8):1109-1112. PubMed ID: 37459615 [TBL] [Abstract][Full Text] [Related]
7. Community-based opioid overdose prevention programs providing naloxone - United States, 2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174 [TBL] [Abstract][Full Text] [Related]
8. Addiction stigma and the production of impediments to take-home naloxone uptake. Fomiatti R; Farrugia A; Fraser S; Dwyer R; Neale J; Strang J Health (London); 2022 Mar; 26(2):139-161. PubMed ID: 32529843 [TBL] [Abstract][Full Text] [Related]
9. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments. Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268 [TBL] [Abstract][Full Text] [Related]
10. Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine. Strang J; McDonald R; Campbell G; Degenhardt L; Nielsen S; Ritter A; Dale O Drugs; 2019 Sep; 79(13):1395-1418. PubMed ID: 31352603 [TBL] [Abstract][Full Text] [Related]
11. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose. Dora-Laskey A; Kellenberg J; Dahlem CH; English E; Gonzalez Walker M; Brummett CM; Kocher KE Acad Emerg Med; 2022 Apr; 29(4):442-455. PubMed ID: 34962682 [TBL] [Abstract][Full Text] [Related]
12. Barriers to and recommendations for take-home naloxone distribution: perspectives from opioid treatment programs in New Mexico. Salvador JG; Sussman AL; Takeda MY; Katzman WG; Moya Balasch M; Katzman JG Harm Reduct J; 2020 May; 17(1):31. PubMed ID: 32404109 [TBL] [Abstract][Full Text] [Related]
13. The changing landscape of naloxone availability in the United States, 2011 - 2017. Freeman PR; Hankosky ER; Lofwall MR; Talbert JC Drug Alcohol Depend; 2018 Oct; 191():361-364. PubMed ID: 30195192 [TBL] [Abstract][Full Text] [Related]
14. Local health departments and the implementation of evidence-based policies to address opioid overdose mortality. Feuerstein-Simon R; Lowenstein M; Sharma M; Dupuis R; Luna Marti X; Cannuscio CC Subst Abus; 2020; 41(4):468-474. PubMed ID: 32213045 [TBL] [Abstract][Full Text] [Related]
15. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation. McDonald R; Campbell ND; Strang J Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870 [TBL] [Abstract][Full Text] [Related]
16. A systematic review exploring healthcare professionals' perceptions of take-home naloxone dispensing in acute care areas. Osinski K; Afseth J J Adv Nurs; 2024 Nov; 80(11):4361-4371. PubMed ID: 38563492 [TBL] [Abstract][Full Text] [Related]
18. Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder? Adeosun SO J Pharm Pract; 2023 Aug; 36(4):941-952. PubMed ID: 35505618 [TBL] [Abstract][Full Text] [Related]
19. Development of a take-home naloxone program at an urban academic emergency department. Eswaran V; Allen KC; Cruz DS; Lank PM; McCarthy DM; Kim HS J Am Pharm Assoc (2003); 2020; 60(6):e324-e331. PubMed ID: 32690447 [TBL] [Abstract][Full Text] [Related]
20. Rhode Island's Opioid Overdose Hospital Standards and Emergency Department Naloxone Distribution, Behavioral Counseling, and Referral to Treatment. Samuels EA; Wentz A; McCormick M; McDonald JV; Marshall BDL; Friedman C; Koziol J; Alexander-Scott NE Ann Emerg Med; 2021 Jul; 78(1):68-79. PubMed ID: 33865617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]